EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC-ND 4.0

Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancer

Steven H Liang

Acta Pharmaceutica Sinica B · 2026-05 · 16 (5) · 3249-3250

DOI: 10.1016/j.apsb.2026.04.013 ↗

Kurz gefasst

Editorial in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-05. Verfasst von Steven H Liang. Beteiligte Einrichtung: Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30322, USA. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Hypoxia-selective cytotoxicityJAK/STAT3 signalingTriple-negative breast cancereEF1A1

Autor:innen und Institutionen

  • Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30322, USA.

Zitieren

APA

Liang, S. H. (2026). Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancer. Acta Pharmaceutica Sinica B, 16(5), 3249-3250. https://doi.org/10.1016/j.apsb.2026.04.013

Vancouver

Liang SH. Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancer. Acta Pharmaceutica Sinica B. 2026;16(5):3249-3250. doi:10.1016/j.apsb.2026.04.013

BibTeX
@article{Liang2026,
  author = {Liang, Steven H},
  title = {Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancer},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {3249--3250},
  doi = {10.1016/j.apsb.2026.04.013}
}
Kostenlos starten →